Literature DB >> 4025130

Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.

A Kimchi, A G Ellrodt, Y Charuzi, W Shell, G H Murata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4025130     DOI： 10.1016/0002-8703(85)90180-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  10 in total

Review 1.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 2.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 3.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

4.  Acute haemodynamic and neurohumoral effects of intravenous nisoldipine in patients with severe congestive heart failure.

Authors:  H H Erlemeier; W Kupper; W Bleifeld
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction.

Authors:  E E van der Wall; V M Cats; J C Chin; E J Pauwels; A V Bruschke
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

6.  The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.

Authors:  R C de Nooijer; E E van der Wall; V M Cats; G van Herpen; A van der Laarse; J A Blokland; W Jaarsma; J W Arndt; A V Bruschke
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 7.  The pharmacology of nisoldipine.

Authors:  A Knorr
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

8.  Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.

Authors:  J van Harten; P van Brummelen; J H Wilson; M T Lodewijks; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Nisoldipine and perfusion of post-stenotic myocardium in conscious pigs with different degrees of concentric stenosis.

Authors:  D J Duncker; J P Heiligers; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.

Authors:  J van Harten; P van Brummelen; R R Zeegers; M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.